Condition: EBV Infection · Sponsor: Huazhong University of Science and Technology
Immunocompetent subjects with high load of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood will be enrolled and prospectively followed up to track the natural histories of the chronic high load of EBV virus. The primary goal of this study is to explore the association of peripheral high load of EBV with the hematological malignancies, and second goal is to investigate the genetic mechanisms of immune escape and tumorigenesis of chronic EBV infection.
This description comes directly from the study's public registry record.
Jin Huang, PhD.and MD. · 86-15926444318 · hj20130318@163.com
Jianfeng Zhou, PhD.and MD. · 86-13627284963 · jfzhou@tjh.tjmu.edu.cn
Always discuss trial participation with your own doctor first.
| Tongji hospital, Tongji medical collage of HUST | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03491605